We're so proud of everything you've accomplished here, and can't wait to see what you do next.
A new paper published by Kevin Esvelt lays out a blueprint for preventing, preparing for, and responding to future pandemics.
We're thrilled to welcome our friends at the Museum to Kendall Square!
Kevin Esvelt and Gigi Gronvall join Ryan Grim and Emily Jashinky to discuss Gain of Function research, and Covid Origin Theory.
If fewer mice carry Lyme, the scientists say, fewer ticks that bite them would become infected.
The SLAS Innovation Award is a $10,000 cash prize recognizing the work behind one exceptional podium presentation.
Using a new robotic platform, researchers can simultaneously track hundreds of microbial populations as they evolve new proteins.
Kevin Esvelt calls on the research community to build defenses against future pandemics, not attempt to discover viruses that cause them.
The people in the 16th annual celebration of young innovators are disrupters and dreamers.
MIT biologist Kevin Esvelt discusses the biology of the pandemic and how gain-of-function research jeopardizes public safety.
Esvelt and Lipsitch lay out a path for slowing the spread of B.1.1.7, and ensuring that we're better prepared for future pandemics.
Kevin Esvelt, master's student Anika Ullah, and other experts talk about bi-directional contact tracing, privacy, and halting Covid-19.
We used a secret time machine under the MIT dome to go to the year 2050 and see what’s going on there!
An inventor of CRISPR-based gene drive has some advice to improve science, ethics, and the life-saving potential of these technologies.
Kevin Esvelt and other experts talk about the risks and possible benefits of using gene drives to eliminate diseases and invasive species.
Read the FAQ that accompanies the op-ed by Kevin Esvelt and Carolyn P. Neuhaus, which answers questions about the research they're proposing
We don’t know, but the idea is hardly crazy—and if the answer is yes, we could save many lives long before a vaccine arrives
August 20, 2020
To date, two Media Lab projects have received RAPID grants for work related to the Covid-19 pandemic.
Kevin Esvelt and other experts talk to Axios about the risk of, and potential defenses against, engineered pathogens.
An MIT research team is using supercomputers to help develop a drug to treat the disease caused by the novel coronavirus.
Esvelt's career has gone from straight science into ethics and safety.
How biologist Kevin Esvelt came to know the planet, in his own words.
Kevin Esvelt has been named as one of the Inverse Future 50, “a group of 50 people who will be forces of good in the 2020s.”
The Media Lab community brings creativity, expertise, and research to the pandemic
Sculpting Evolution head Kevin Esvelt shares how emerging technologies can help us fight the new coronavirus.
Kevin Esvelt and other experts discuss potential technological approaches to combating mosquito-borne diseases.
Unnatural Selection tackles tough questions about CRISPR gene editing, designer babies, and more.
How does one scientist deal with the potential ramifications of his own creation?
The menacing mites have invaded suburban backyards and even parts of Boston. And Lyme disease isn’t the only thing they carry.
Kevin Esvelt writes about the Sculpting Evolution group’s project to immunize mice against Lyme disease through gene editing.
On Should This Exist?, Sculpting Evolution head Kevin Esvelt grapples with the potential benefits and consequences of gene drive.
Congratulations to all of the honorees! We are so proud of you all.
In a paper published in PNAS, researchers at MIT and Harvard University describe a self-limiting gene drive system.
Scientists hope these genetically modified "gene drive" mosquitoes could help eradicate malaria.
Avery Normandin and Devora Najjar are on a mission to build literacy and appreciation for urban ecology.
Cummings School and MIT are working with Massachusetts citizens to deploy immune mice as frontline soldiers in the war against the disease.
iBiology features two introductory classes from CRISPR expert Kevin Esvelt, head of the Media Lab's Sculpting Evolution group.
Unlike a normal edit, gene drive systems could lastingly alter or suppress local or global populations of a target species.
After researchers resurrected a long-dead pox, some critics argue that it's too easy for scientists to make decisions of global consequence.
Cryptography techniques to screen synthetic DNA could help prevent the creation of dangerous pathogens, argues Professor Kevin Esvelt
Given the power to alter the workings of the natural world, are we morally obligated to use it?
I'm a strong advocate of more open science, and my group tries to carefully consider our moral obligations and publicly admit mistakes.
Scientists are developing new ways to alter the genetic code of living organisms. John Oliver explores the risks and rewards.
There’s a huge opportunity to improve agriculture with gene editing. But we need to give CRISPR a chance.
The debate over whether to use genetically modified mosquitoes to fight malaria, explained.
A revolution in gene editing enables scientists to create and edit DNA like never before.
Celebrating Brain Awareness Week with a look at some of the Media Lab's brain research
What counts here—first and last—is not so-called knowledge of so-called facts, but vision—seeing. Seeing here implies Schauen [to see] (as …
By Kevin EsveltResearchers should hold themselves morally accountable for all of the consequences of their work. That can require publ…
NANTUCKET, Mass. -- On the picturesque island of Nantucket, residents are considering a radical approach to fight a disease that's haunted …
Awards support high-risk, high-impact biomedical research.
Lyme disease has become part of daily life for residents on the rural Massachusetts islands of Nantucket and Martha’s Vineyard, where the t…
Kevin Esvelt argues that the tremendous power of CRISPR can only be contained if scientists are open about their research.
The capabilities of “gene drive” are thrilling—and also terrifying.